Amgen has transitioned into a mature, cash-generating pharma-biotech hybrid. Click here to find out why AMGN stock is a Buy.

Samsung today lost its bid at the U.S. Court of Appeals for the Federal Circuit (CAFC) to transfer a suit brought against it ...

Brown University scholars work to turn breakthroughs and discoveries into technologies that enhance lives, placing the ...

An undeniable off-white and royal blue has crashed the Nike scene, arriving in the form of an Air Jordan 11—specifically the ...

U.S. telehealth upstart Hims & Hers Health, Inc. is planning to enter the Canadian market with an eye to selling generic ...

Evoke Pharma shares surged after the company received a notice of allowance for a U.S. patent application for Gimoti extending Orange Book listings to 2036.

Merck & Co., Inc. is acquiring Verona Pharma plc for $10bn to bolster long-term growth with COPD drug Ohtuvayre. Click for my ...

A new patent granted to Apple reveals that a next-gen Apple Pencil could work with your iPhone, but also many other devices.

The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug ...

The move bolsters Merck's lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda. Prosecutors Question Doctors About UnitedHealth's Medicare Billing Practices ...

Pip Edwards was turning heads as she attended a L'Oréal event on Wednesday night.  The P.E Nation designer stepped out at the ...

In 1996, a gathering of master distillers revisited traditional whiskey-making wisdom from generations past. Nearly three ...